Get the Stockscreener App
1.10
1.79%
-0.02
Pyxis Oncology Inc stock is traded at $1.10, with a volume of 163.98K.
It is down -1.79% in the last 24 hours and up +1.85% over the past month.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
See More
Previous Close:
$1.12
Open:
$1.1
24h Volume:
163.98K
Relative Volume:
0.32
Market Cap:
$68.14M
Revenue:
-
Net Income/Loss:
$-73.79M
P/E Ratio:
-0.5978
EPS:
-1.84
Net Cash Flow:
$-77.44M
1W Performance:
-12.00%
1M Performance:
+1.85%
6M Performance:
-29.94%
1Y Performance:
-70.19%
1-Day Range:
$1.085
$1.13
1-Week Range:
$1.085
$1.28
52-Week Range:
$0.8332
$5.3899
Pyxis Oncology Inc Stock (PYXS) Company Profile
Name
Pyxis Oncology Inc
Sector
Industry
Phone
(617) 221-9059
Address
321 HARRISON AVENUE, BOSTON
Compare PYXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PYXS
Pyxis Oncology Inc
|
1.10 | 69.38M | 0 | -73.79M | -77.44M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-21-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-08-24 | Initiated | Stephens | Overweight |
| Aug-08-24 | Initiated | Stifel | Buy |
| May-07-24 | Resumed | Jefferies | Buy |
| Feb-09-24 | Initiated | BTIG Research | Buy |
| Jan-23-24 | Initiated | Leerink Partners | Outperform |
| Sep-05-23 | Initiated | RBC Capital Mkts | Outperform |
| Nov-02-21 | Initiated | BofA Securities | Neutral |
| Nov-02-21 | Initiated | Credit Suisse | Outperform |
| Nov-02-21 | Initiated | Jefferies | Buy |
View All
Pyxis Oncology Inc Stock (PYXS) Latest News
Can Pyxis Oncology Inc. recover in the next quarterFree Reversal Alert Based on RSI Indicator - Newser
How Pyxis Oncology Inc. stock performs during market volatilityAI Trade Signal Forecast with Chart Logic - Newser
Pyxis Oncology Inc. Consolidation Zone May Signal AccumulationLow Capital High Return Stock Plans Reviewed - metal.it
Will Pyxis Oncology Inc. outperform the market3-Day Market Movement Forecast Analysis - Newser
How to integrate Pyxis Oncology Inc. into portfolio analysis toolsFast Entry Strategy with Price Prediction - Newser
Real time scanner hits for Pyxis Oncology Inc. explainedEquity Signal Recap With Long-Term Summary - Newser
Should I hold or sell Pyxis Oncology Inc. stock in 2025AI Powered Planner Backed By Experts - jammulinksnews.com
What are the technical indicators suggesting about Pyxis Oncology Inc.Best Dividend Report From AI Tools - jammulinksnews.com
Should you hold or exit Pyxis Oncology Inc. nowFree Consistent Income Focused Trade List - Newser
Why Pyxis Oncology Inc. stock attracts strong analyst attentionFree AI Screening for Swing Trade Picks - Newser
Live Scanner Shows Breakout on Pyxis Oncology Inc.Stock Selection With High Accuracy Based on Models - metal.it
Risk adjusted return profile for Pyxis Oncology Inc. analyzedSmart Trade Forecast Based on Neural Logic - Newser
Bullish Candlestick Pattern Forms in Pyxis Oncology Inc.Real Time Alerts Based on AI Prediction Triggered - metal.it
Chartists See Breakout Potential in Pyxis Oncology Inc.Growth Focused Entry Plan Suggestions Issued - metal.it
What makes Pyxis Oncology Inc. stock price move sharplyBuild wealth steadily with smart trading - jammulinksnews.com
What is the dividend policy of Pyxis Oncology Inc. stockTremendous financial leverage - jammulinksnews.com
When is Pyxis Oncology Inc. stock expected to show significant growthExceptional profit velocity - jammulinksnews.com
Will Pyxis Oncology Inc. Stock Benefit from AI and Green Energy TrendsHigh Reward Risk Balanced Trading - Newser
Key External Factors That Drive Pyxis Oncology Inc. Stock Price MovementsFree Access to Community with 300% Return - Newser
Is Pyxis Oncology Inc. a good long term investmentFree Real-Time Stock Data - PrintWeekIndia
Can Pyxis Oncology Inc. stock recover from recent declineExplosive wealth accumulation - jammulinksnews.com
What analysts say about Pyxis Oncology Inc. stockConsistently outstanding ROI - PrintWeekIndia
Pyxis Oncology Inc’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com
Pyxis Oncology Inc. Stock Analysis and ForecastFree Stock Movement Tracking - jammulinksnews.com
What drives Pyxis Oncology Inc. stock priceExtraordinary performance - jammulinksnews.com
Pyxis Oncology Inc Stock (PYXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):